Home » Research Summaries » Search Results
Archives: Research Summaries

Journal: Multiple Sclerosis and Related Disorders; August 1, 2025
Author(s): Kshiteeja Jain, Kamakshi Dhamija, Vikram V Holla, K Thennarasu, Maya Bhat, Anita Mahadevan, M Netravathi
How MOGAD patients respond to azathioprine, mycophenolate mofetil, or rituximab: A study from India

Journal: Neurology and Therapy; June 12, 2025
Author(s): Jeffrey L. Bennett, Asha Paireddy, Charlotte Cox, Megan Mayhew, Julia Stein, Teresa Gasalla, Béatrice Tugaut
What is life like for people with MOGAD? A visual model informed by patient and clinician interviews

Journal: Journal of Neurology; July 8, 2024
Author(s): Hesham Abboud, Rongyi Sun, Nikhil Modak, Mohamed Elkasaby, Alexander Wang & Michael Levy
How common are movement disorders such as spasms, muscle contractions, and tremors in neuroimmune diseases?

Journal: Multiple Sclerosis and Related Disorders; May 1, 2024
Author(s): Christina Kazzi, Rubina Alpitsis Terence J. O'Brien, Charles B. Malpas, Mastura Monif
Impact of NMOSD and MOGAD on thinking abilities and emotions

Journal: Journal of Neurology, Neurosurgery, & Psychiatry; December 1, 2024
Author(s): Vivien Häußler, Corinna Trebst, Daniel Engels, Hanna Pellkofer, Joachim Havla, Ankelien Duchow, Patrick Schindler, Carolin Schwake, Thivya Pakeerathan, Katinka Fischer, Marius Ringelstein, Gero Lindenblatt, Martin W Hümmert, Daria Tkachenko, Franziska Bütow, Katrin Giglhuber, Martina Flaskamp, Insa Schiffmann, Mirjam Korporal-Kuhnke, Sven Jarius, Eva Dawin, Lisa Revie, Makbule Senel, Mariella Herfurth, Annette Walter, Mosche Pompsch, Ingo Kleiter, Klemens Angstwurm, Matthias Kaste, Matthias Grothe, Jonathan Wickel, Paulus Stefan Rommer, Jörn Peter Sieb, Markus Krämer, Florian Then Bergh, Hayrettin Tumani, Luisa Klotz, Brigitte Wildemann, Orhan Aktas, Ilya Ayzenberg, Judith Bellmann-Strobl, Friedemann Paul, Tania Kümpfel, Tim Friede, Achim Berthele, Jan-Patrick Stellmann on behalf of the Neuromyelitis optica study group (NEMOS)
How are immunosuppressive treatments chosen and how effective are they in normal care?

Journal: Journal of Neurology; December 1, 2024
Author(s): Mihaela Nicolescu, Vivien Häußler, Friedemann Paul, Frederike Cosima Oertel, Patrick Schindler, Judith Bellmann Strobl, Markus Krumbholz, Martin W. Hümmert, Franziska Bütow, Daria Tkachenko, Corinna Trebst, Charlotte Schubert, Ilya Ayzenberg, Carolin Schwake, Thivya Pakeerathan, Katinka Fischer, Orhan Aktas, Marius Ringelstein, Markus Kraemer, Clemens Warnke, Matthias Grothe, Matthias Kaste, Klemens Angstwurm, Peter Kern, on behalf of the Neuromyelitis Optica Study Group (NEMOS)
How is vision and vision-related quality of life affected in NMOSD, MOGAD, and MS patients?

Journal: Multiple Sclerosis and Related Disorders; November 1, 2024
Author(s): Hyun Ji Lyou, Ha Young Shin, Hye Lim Lee, Young Nam Kwon, Seong-il Oh, Jeeyoung Oh, Eun Bin Cho, Sunyoung Kim, Seol-Hee Baek, Byung-Jo Kim, Eunhee Sohn, Jin Myoung Seok, Ju-Hong Min, Seung Woo Kim, Byoung Joon Kim
Comparing quality of life in NMOSD and MOGAD patients in South Korea

Journal: PLOS One; March 29, 2024
Author(s): Darcy C Esiason, Nicole Ciesinski, Chelsi N Nurse, Wendy Erler, Tom Hattrich, Ankita Deshpande, C Virginia O'Hayer
The emotional burden of NMOSD on patients and caregivers

Journal: Journal of Neurology, Neurosurgery, & Psychiatry; July 30, 2024
Author(s): Sarah Passoke, Carlotta Stern, Vivien Häußler, Tania Kümpfel, Joachim Havla, Daniel Engels, Sven Jarius, Brigitte Wildemann, Mirjam Korporal-Kuhnke, Makbule Senel, Jan-Patrick Stellmann, Clemens Warnke, Matthias Grothe, Rasmus Schülke, Stefan Gingele, Julian Reza Kretschmer, Luisa Klotz, Annette Walter, Florian Then Bergh, Orhan Aktas, Marius Ringelstein, Ilya Ayzenberg, Carolin Schwake, Ingo Kleiter, Pia Sophie Sperber, Rebekka Rust, Patrick Schindler, Judith Bellmann-Strobl, Friedemann Paul, Bruno Kopp, Corinna Trebst, Martin W Hümmert on behalf of the Neuromyelitis Optica Study Group (NEMOS)
How does MOGAD affect cognitive function (thinking and language-processing skills) over time?

Journal: Autoimmunity Reviews; January 3, 2025
Author(s): Benjamin P Trewin, Fabienne Brilot, Stephen W Reddel, Russell C Dale, Sudarshini Ramanathan
Disease features, treatment, and results in about 4700 MOGAD patients globally